<< Back to News

System Formulary Addition
Lurbinectedin Injection

Situation

The formulary review of lurbinectedin injection was approved at the October 2020 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was requested for formulary addition: lurbinectedin injection (Zepzelca)

Assessment/Recommendation

Go-Live: Tuesday, December 15, 2020

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Lurbinectedin injection 4 mg

Use of lurbinectedin injection is restricted to patients in outpatient or clinic encounters (ie, no inpatient use)

Lurbinectedin orders must be signed by a Hematology/Oncology Attending Physician

Note: Stock of these formulary products may vary at individual entities